Article
Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Cancer genetics - 1 Mar 2013
Rodríguez-Vicente Ana E, Díaz Marcos González, Hernández-Rivas Jesús M
Abstract excerpt
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival times ranging from months to decades, reflects its biological diversity. Our understanding of the biology of CLL has helped us identify several markers of prognostic significance, by which CLL can be differentiated into several distinct diseases. The presence of specific chromosomal abnormalities is a prognostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
